Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Link between metabotropic glutamate receptor and fragile X syndrome seen in mice

Jan. 8, 2008

Significant treatment effect seen with gepirone ER in depression studies

Jan. 8, 2008

FDA grants orphan drug designation to Ovation's clobazam for Lennox-Gastaut syndrome

Jan. 7, 2008

Recent Roche patent describes new cognition enhancers for Alzheimer's disease

Jan. 7, 2008

Promising results with antisense oligonucleotide PRO-051 in Duchenne's muscular dystrophy

Jan. 7, 2008

Studies evaluate prevention of post-stroke depression, PTSD with escitalopram

Jan. 7, 2008

Levetiracetam shows promise in body dysmorphic disorder

Jan. 7, 2008

Adjunctive topiramate decreases compulsions in obsessive-compulsive disorder

Jan. 7, 2008

Addex announces ADX-10059 phase IIa acute anxiety data

Jan. 4, 2008

FDA approves Shire's new dosages for ADHD treatment Vyvanse

Jan. 4, 2008

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...